Mellingen, Switzerland

Frieder W Merz



 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Frieder W Merz

Introduction

Frieder W Merz, a prominent inventor based in Mellingen, Switzerland, has made significant strides in the field of biotechnology. With a total of six patents to his name, Merz has devoted his career to innovating therapeutic solutions using designed ankyrin repeat proteins. His contributions reflect a deep understanding of protein engineering and its applications in medicine.

Latest Patents

Merz's latest patents cover groundbreaking advancements in designed ankyrin repeat proteins. One notable patent involves the development of new designed ankyrin repeat proteins that specifically bind to hepatocyte growth factor (HGF). These proteins, along with the nucleic acids encoding them, hold promise for treating various diseases through innovative pharmaceutical compositions. Another important patent focuses on recombinant binding proteins that contain multiple designed ankyrin repeat domains, allowing for specific binding to serum albumin, HGF, and vascular endothelial growth factor (VEGF-A). This work opens up new avenues for therapeutic interventions in several health conditions.

Career Highlights

Frieder W Merz is associated with Molecular Partners AG, a company renowned for its pioneering research in the field of protein therapeutics. His work is characterized by a blend of scientific rigor and innovation, positioning him as a leader in designing binding proteins that have the potential to address critical health challenges. Merz's patents not only highlight his technical expertise but also his commitment to translating scientific discoveries into practical applications.

Collaborations

Throughout his career, Merz has collaborated with several distinguished professionals, including Douglas Phillips and Hans Kaspar Binz. These partnerships underscore the collaborative nature of scientific research, where diverse expertise converges to drive innovation and enhance the impact of work in the field of biotechnology.

Conclusion

Frieder W Merz’s contributions to the realm of designed ankyrin repeat proteins demonstrate his brilliance as an inventor. With six patents to his credit, he continues to shape the future of therapeutic strategies in medicine. His ongoing work at Molecular Partners AG and collaborations with esteemed colleagues indicate a promising horizon for breakthroughs in biotechnology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…